Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 58 Sarcoma 39 Neoplasm Metastasis 22 Neoplasms 20 Ovarian Neoplasms 17 Breast Neoplasms 17 Carcinoma, Non-Small-Cell Lung 15 Recurrence 7 Leiomyosarcoma 7 Kidney Neoplasms 7 Melanoma 6 Liposarcoma 6 Hemangiosarcoma 6 Glioblastoma 6 Fallopian Tube Neoplasms 6 Thyroid Neoplasms 5 Prostatic Neoplasms 5 Neurofibrosarcoma 5 Lung Neoplasms 5 Urinary Bladder Neoplasms 4 Sarcoma, Synovial 4 Pancreatic Neoplasms 4 Osteosarcoma 4 Histiocytoma, Malignant Fibrous 4 Dermatofibrosarcoma 4 Clear-cell metastatic renal cell carcinoma 4 Chondrosarcoma, Extraskeletal Myxoid 4 Uterine Cervical Neoplasms 3 Solid Tumors 3 Small Cell Lung Carcinoma 3

Interventions

Paclitaxel 9 apatinib 8 Capecitabine 7 Oxaliplatin 6 Cisplatin 5 camrelizumab 4 S 1 (combination) 4 Fluorouracil 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 titanium silicide 2 Leucovorin 2 vorolanib 1 trifluridine tipiracil drug combination 1 tipiracil 1 spartalizumab 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 lobaplatin 1 linrodostat 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 Trifluridine 1 Sunitinib 1 SHR-1701 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Gastric Cancer × pazopanib × Clear all

NCT01503372 2019-02-12

PaFLO

Charite University, Berlin, Germany

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡